Dialybrid S.r.l.
PrivateLast Round
Series A
Sep 22, 2026
Total Funding Raised
$17.55M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Dialybrid S.r.l. is a medical device company that develops and commercializes novel arteriovenous vascular grafts for hemodialysis using its proprietary Silkothane® technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dialybrid S.r.l. Comparables
Compare Dialybrid S.r.l. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anova Biomedical | 86% | |
| Xeltis | 78% | |
| Healionics Corporation | 77% |
Dialybrid S.r.l. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2026 | ||||
| Seed | Aug 4, 2020 |
Dialybrid S.r.l. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XGEN Venture | Series A |
| CDP Venture Capital SGR | Series A |
| LIFTT EuroInvest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
$17M round led by XGEN Venture.
- Aug 4, 2020
$350K round led by LIFTT EuroInvest
Recent news
Latest coverage and updates
- is_developingSep 22, 2026
Dialybrid is developing novel vascular access solution for hemodialysis based on Silkothane on Sep 22nd '26.
- attends_eventSep 22, 2026
Dialybrid will attend event LSI Europe '26 Emerging Medtech Summit on Sep 29th '26.
- receives_financingSep 22, 2026
Dialybrid received financing of $17.2M in Series A on Sep 22nd '26.
Dialybrid S.r.l. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dialybrid S.r.l.'s valuation, stock price, and market status.
Is Dialybrid S.r.l. a public or private company?
Dialybrid S.r.l. is a private company.
What is the current stock price of Dialybrid S.r.l.?
Dialybrid S.r.l. is a private company with no public stock price. No recent secondary market data is available.
How much is Dialybrid S.r.l. worth (valuation)?
Valuation information for Dialybrid S.r.l. is not publicly available.
Can I buy Dialybrid S.r.l. stock?
Dialybrid S.r.l. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Dialybrid S.r.l.'s last funding round?
Dialybrid S.r.l.'s most recent funding round was Seed on August 4, 2020.
Who are the main investors in Dialybrid S.r.l.?
Key investors in Dialybrid S.r.l. include LIFTT EuroInvest.
Will Dialybrid S.r.l. IPO soon?
No public IPO plans have been announced for Dialybrid S.r.l..
How can I track Dialybrid S.r.l. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dialybrid S.r.l.'s secondary market activity and sign up for updates.